Intensive subsidy necessary on growth potential products.

Published: 2004-11-01 06:57:00

Updated: 2004-11-01 06:57:00

Dr. Han Byeong-hyeon of the Korea Health Industry Development Institute (KHIDI) recently reported in his paper titled "The present status and its development plans for pharmaceutical industry" that the intensive supports on the growth potential products, the infrastructure buildup for the global ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK